Alejandro Vázquez‐Martín

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

Alejandro Vázquez‐Martín, Cristina Oliveras‐Ferraros, Javier A. Menéndez · Cell Cycle · 2009 · 251 citations · Full text

Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab

Alejandro Vázquez‐Martín, Cristina Oliveras‐Ferraros, Javier A. Menéndez · PLoS ONE · 2009 · 244 citations · Full text

Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin

Juan Manuel Iglesias, Izaskun Beloqui, Francisco García‐García et al. · PLoS ONE · 2013 · 210 citations · Full text

Breast Oncology, Pathology, Viability Drops +17

Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis

Sílvia Cufí, Alejandro Vázquez‐Martín, Cristina Oliveras‐Ferraros et al. · Cell Cycle · 2010 · 209 citations · Full text

Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status

Alejandro Vázquez‐Martín, Cristina Oliveras‐Ferraros, Sílvia Cufí et al. · Cell Cycle · 2010 · 201 citations · Full text

Breast Oncology, Cancer Biology, Mammary Gland Development +22